2019 Categories

1. Best Technological Innovation: Devices and Diagnostics
2. Best Technological Innovation: Digital
3. Executive of the Year
4. Most Innovative Team or Innovator of the Year
5. Community Partnership of the Year
6. Best Proof-of-Value of an Innovation
7. Financing of the Year
8. Dealmaker of the Year
9. The In Vivo Award for Best Medtech Partnership/Alliance
   
   

Best Technological Innovation: Devices and Diagnostics

Innovation is the life blood of the medtech industry. This Award will recognize the efforts of an individual, team, or company that developed an innovative medical device or diagnostic that makes significant contributions to advancing patient treatment and was launched in between June 1, 2018 and June 29, 2019. The judges will be looking for the product that represents the most innovative new approach to care by addressing an unmet clinical need; by changing the practice of health care to be more effective, efficient or less error-prone; or by expanding technology to new patient populations.

To be eligible, entrants must have played a role in the core project for the product.

To enter this category, please provide the following:

• The name of the individual, team or company, including an outline of their role(s).
• Details of the product; i.e. type of product, name(s), procedure, patient segment(s)
• Provide evidence of the impact that the product has had, or potentially could have, on the patient population and addressing unmet medical needs
• Describe any unique strategies used to identify market needs, prototype, bench test, develop clinical protocols or take on other steps of the innovation process.
• If available, please provide documentation (URL) in support of the achievements described

Best Technological Innovation: Digital

This Award will recognize the efforts of an individual, team, or company that developed an innovative digital health tool or standalone software that makes significant contributions to advancing patient health and was launched in between June 1, 2018 and June 29, 2019. The judges will be looking for the product that supports the most innovative new approach to care by addressing an unmet clinical need; by changing the practice of health care to be more effective, efficient or less error-prone; or by expanding technology to new patient populations.

To be eligible, entrants must have played a role in the core project for the product.

To enter this category, please provide the following:

• The name of the individual, team or company, including an outline of their role(s).
• Details of the product; i.e. type of product, name(s), procedure, patient segment(s)
• Provide evidence of the impact that the product has had, or potentially could have, on the patient population and addressing unmet medical needs
• Describe any unique strategies used to identify market needs, prototype, bench test, develop clinical protocols or take on other steps of the innovation process.
• If available, please provide documentation (URL) in support of the achievements described

Executive of the Year

The Medtech Insight Executive of the Year Award is designed to acknowledge excellence in the leadership of large and small medtech companies. This year’s winner will be the executive who has exhibited exemplary leadership throughout 12 months from June 1, 2018 to June 29, 2019.

This could range from leading an emerging company to an established place within the industry, to turning around the fortunes of a failing company or unit or leading a firm successfully through the turbulence of a merger or acquisition. Also important to the judges will be the executive’s career achievements, influence within the industry and leadership qualities.

To be eligible for this year’s Award, entrants must hold a C-suite executive position. Candidates must be employed by the company at the time of nomination.

To enter this category, please answer the following:

• Please give the name, company and position of the entrant, and the date of taking up this post.
• What have been the entrant’s greatest achievements during the qualifying year? What has been the direct consequence of these on company performance?
• How have these achievements strengthened the candidate’s influence within the industry? Please give examples.
• What are the entrant’s greatest strengths as a leader? Please show how these have had a bearing on their achievements this year.
• What specific previous accomplishments did the entrant have that made them perfectly fitted to achieving this success? For example, previous scientific or management experience.

Most Innovative Team or Innovator of the Year

This Award will recognize the medical technology team who have made significant contributions in the device and diagnostic space between June 1, 2018 and June 29, 2019. The judges will be looking to reward the high performing team that has been most successful in reaching its goals, adopted innovative working practices, achieved major milestones within expected timelines, and contributed to the advancement of medical technology for unmet medical needs.

To be eligible, the core project for the nominated team must be ongoing or completed during 2018/9. 

Entrants must have played a role in the core project for the product.

To enter this category, please provide the following:

• The company’s name, the team or individual being entered and basic details of its core project during 2018/9
• What was the greatest achievement of the team or individual during the qualifying period?
• How did the individual or members/functions of the team work together to achieve its goals?
• How does the achievement contribute to advancing medical technology for unmet medical needs?
• What innovative work practices has the team or individual adopted to drive success?
• If you believe that this team or individual is particularly outstanding, but for reasons not covered in the questions above, please give relevant details.

Community Partnership of the Year

This award is designed to acknowledge the numerous ways in which medtech companies give back to the wider community. This could include outreach within a local community, with a charity or patient advocacy group, or alongside an NGO or humanitarian organization.

The judges will be looking for effective partnership activity that took place between June 1, 2018, and June 29, 2019, to the benefit of humankind. Types of partnerships could include, for example, patient and career support programs, educational programs or disease awareness campaigns or even a social media campaign that went viral.

To enter this category, please answer the following:

• Please give the name of the entering company and the name of the partnership
• Please outline the nature of the partnership being entered
• What were the aims of the partnership?
• What were the benefits of the partnership and how were they measured?
• What lessons were learned from the partnership and how might it be improved in future?

Best Proof-of-Value of an Innovation

This Award will recognize a company or division that has taken an innovative or creative approach to demonstrating the value of its product(s) to the health-care sector. Examples may include approaches to data collection, service offerings, digital capabilities, creative risk-sharing partnerships with providers or insurers, or other models that serve to demonstrate a products value to providers, patients and other health-care stakeholders between June 1, 2018 and June 29, 2019.

To enter this category, please provide the following:

• The company’s name, the team being entered and basic details of the core project.
• A description of the proof-of-value strategy, its intended outcomes and metrics.
• How has the strategy achieved an outcome that would not have been possible if it had not been created?
• What makes the strategy particularly novel?
• How has the approach set a new model or benchmark for other products or markets?
• If available, please provide documentation (URL) in support of the achievements described.

Financing of the Year

This award seeks to reward successful and creative fundraising by medtech companies. The investment can come in a variety of guises from grants and public-private partnership deals to venture fundraising and public offerings.

In making their decision, the judges will scrutinize entrants on their fundraising strategy, amount raised, the structure of the deal, and on how the money will be used. This Award is open only to companies actually raising the funds (i.e., not bankers or agents). To be eligible, all financing must have been announced between June 1, 2018 and June 29, 2019.

To enter this category, please answer the following questions:

• Please outline the form of the financing, how much money was raised (including how this compares with the company’s capital base), and how close was this to meeting your fundraising objectives?
• Please explain how this source of financing was best suited to your purposes.
• Please describe how this fundraising was particularly creative. Has this set a precedent that has since been repeated?
• Did the funding succeed in other ways, such as bringing on board a new kind of investor?
• How will the money be used?
• Please give evidence of early value creation from the deal.

Dealmaker of the Year

This award seeks to recognize the company that was most adept at advancing its business through investment deals including M&A, strategic investments, licensing, distribution deals and other arrangements. The entry can either highlight an individual deal that has a big impact on a company's business or a series of deals that demonstrate astute strategy. For an individual fundraising deal, a company should submit in the Financing of the Year category (see above), but a fundraising could be one part of a package of deals that supports entry into the Dealmaker category. The activity highlighted should have be initiated or completed between June 1, 2018 and June 29, 2019.

To enter this category, please answer the following questions:

• Identify specific acquisitions or other deals carried out during the entry period, and the basic details for each deal, including size and rationale.
• Explain how the activity supported your business model, enhanced your competitive advantage or brought your business into new growth markets.
• What made the deal or deal strategy stand out?
• Can you provide early evidence of tangible impact or value creation from the activity?
  
  
  

The In Vivo Award for Best Medtech Partnership/Alliance

This Award will be presented to two or more organizations whose joint activity has set a new benchmark in partnering activity. Partnerships could take place between multiple medical technology and/or pharmaceutical companies or between a medical technology company and a contract research organization, research institute, non-profit, or cooperative group.

To be eligible, the collaborative partnership activity in question must be ongoing or completed between June 1, 2018 and June 29, 2019.

Entrants must have played a role in the collaborative partnership activity, and all joint parties must be disclosed in the application.

To enter this category, please provide the following:

• Provide the names of organizations involved and basic details of the partnership.
• Why was the partnership novel?
• How does this partnership set a new benchmark for other deals?
• How has partnership achieved an outcome that would not have been possible if partnership had not been created?
• If available, please provide documentation (URL) in support of the achievements described.

We are now closed for entries for 2019.